Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIBOD study: clinical validation of dried blood spot sampling for rifampicin analysis
NL-OMON42070Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rifampicin in Tuberculosis (TB) and nontuberculous mycobacteria infection, sponsored by Radboud University Medical Center. Primary endpoints: Association between DBS and venous rifampicin concentrations and Predictive performance of DBS for venous concentration. Planned start Apr 2015; status: withdrawn.
02
Drugs
rifampicin
03
Conditions
Tuberculosis (TB)nontuberculous mycobacteria infection
Beyond the preview
Go deeper on NL-OMON42070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42070.